Governance
Representing the voices of cancer research across Oxford, Oxford Cancer is committed to open and transparent communication with its members and our governance structure reflects this.
The Oxford Cancer Committees include representation from across the full breadth of activity in Oxford. We strive to ensure that the voice of each area of cancer research is represented in our committee structures. In turn, those representatives are not only charged with being ambassadors for their area of expertise but also for the Oxford Cancer network, bringing in more members and expanding the reach of our network.
Through its governance, Oxford Cancer coordinates new initiatives and provides the forum for consensus-building about the overall strategic direction for Oxford, providing a framework in which the individual aims and ambitions of the various constituent parts of the Oxford Cancer network can thrive while being united for maximum impact.
Chair: Professor Mark Middleton, Professor Tim Elliott & Professor Adam Mead
Remit: The Governance Board has the responsibility to oversee, develop, adjust, and approve the strategy of the Centre, including its training programmes. It serves as a decision-making forum to capitalise on strategically important opportunities. Additionally, the board discusses and agrees upon recruitment strategies for the Centre. It ensures the delivery of the Centre's strategy and objectives and verifies that the Centre's branding, press, and research engagement activities align with CRUK's expectations. Furthermore, the Governance Board reviews the Centre's performance and its contribution to the CRUK Centres Network, as well as addresses top-level financial opportunities and challenges. It also evaluates key initiatives proposed by CRUK, Research Councils, the NHS, and other organisations funding cancer research, and assesses the Centre's responses to them.
Committee Members:
- Dr Alex Pemberton
- Dr Andy Peniket
- Dr Anny Sykes
- Dr Brooke Lumicisi
- Dr Elizabeth Mann
- Dr Michael Youdell
- Mr Chris Price
- Mr Dom Tromans
- Mr Simon Crowther
- Ms Leila Whitworth
- Ms Sophie De Gouveia
- Prof. Adam Mead
- Prof. Adrian Banning
- Prof. Freddie Hamdy
- Prof. Gavin Screaton
- Prof. Heidi Johansen-Berg
- Prof. Helen McShane
- Prof. Keith Channon
- Prof. Ketan Patel
- Prof. Mark Middleton
- Prof. Pankaj Roy
- Prof. Tim Elliott
- Prof. Xin Lu
Chair: Professor Mark Middleton, Professor Tim Elliott & Professor Adam Mead
Remit: To determine the strategic direction of Oxford Cancer and to monitor its progress.
Committee Members:
- Dr Alex Pemberton
- Dr Brian Nicholson
- Dr Brooke Lumicisi
- Dr Dan Woodcock
- Dr Elizabeth Mann
- Dr Francoise Howe
- Dr Jens Rittscher
- Dr Michael Youdell
- Mr Dom Tromans
- Ms Kea Hinsley
- Ms Sophie De Gouveia
- Prof. Adam Mead
- Prof. Bethan Psaila
- Prof. Clare Verrill
- Prof. Eileen Parkes
- Prof. Eva Morris
- Prof. Freddie Hamdy
- Prof. Helen Byrne
- Prof. Ian Mills
- Prof. Mark Middleton
- Prof. Sarah Blagden
- Prof. Simon Buczacki
- Prof. Simon Leedham
- Prof. Tim Elliott
- Prof. Xin Lu
Chair: Professor Adrian Harris & Professor Chris Schofield
Remit: To integrate different perspectives and activities from across the cancer research community in a forum which can advise on implications to the Oxford Cancer strategy. The committee is also responsible for overseeing the distribution of the Development Fund scheme and coordinating networking activities for Oxford Cancer.
Committee Members:
- Adrian Harris
- Chris Schofield
- Ahmed Ahmed
- Dan Woodcock
- Dragana Ahel
- Eric O’Neil
- Geoff Higgins
- Kim Midwood
- David Dodwell
- Deborah Goberdan
- Peter McHugh
- Wei Huang
- Natalia Gromak
- Sophie De Gouveia
- Sara Danielli
- Julliet Lwiindi
- Mae Goldgraben
- Chen-Chun Pai
- Dom Tromans
Chair: Professor Mark Middleton, Professor Tim Elliott & Professor Adam Mead
Remit: The Oxford Cancer Board provides strategic leadership and expert guidance to support the University’s interdisciplinary cancer research agenda. The Board advises on senior academic recruitment, identifies priority areas for major funding and philanthropic opportunities, and contributes to the long-term vision for impactful, challenge-led cancer research across Oxford.
Committee Members:
- Prof. Adam Mead
- Prof. Chris Schofield
- Prof. Dame Molly Stevens
- Prof. Fadi Issa
- Prof. Ketan Patel
- Prof. Mark Middleton
- Prof. Philip Awadalla
- Prof. Tim Elliott
- Prof. Udo Opperman
- Prof. Xin Lu